Strategic Report Chairmans Statement A year of opportunity opportunities for sustainable growth.
I am The Group adjusted pre-tax profit was Key points in this section: deeply proud to have been the Chairman of 229.1 million, 29% ahead at reported 998.7m sales and 235.5m this great Company for over nine years and currency.
Adjusted basic earnings per operating profit: 6% organic in my last full year I am pleased to be able share was 29% ahead at 220.5 pence increase in both to report that, despite a very busy year, we 2016: 171.5 pence.
maintained our rigorous focus on organic The pre-tax profit on a statutory basis was Acquisitions add 20% to sales growth and delivered another strong set of 192.5 million 2016: 171.4 million and and 14% to profit results, outperforming our markets.
includes certain items, explained in Note 2.
Total Ordinary dividend increased The statutory basic earnings per share was Financial highlights 214.4 pence 2016: 165.0 pence.
15% to 87.5p per share Sales for the year were 998.7 million, an Unless otherwise stated, all profit measures exclude certain organic increase of 6%: exceeding global Cash and dividends items, as set out and explained in the Financial Review and industrial production growth of 3.4%.
Organic measures are at constant During the year, we had a cash outflow currency and exclude acquisitions.
Favourable currency movements increased of 484 million to fund the acquisitions of sales on translation by 5% and acquisitions Gestra and Chromalox.
As a result, at 31st Introduction added 20%.
As a result, reported sales December 2017 we had a net debt balance My last full year as Chairman was a were 32% higher than 2016.
Our Watsonof 373.6 million, compared with net cash of successful and eventful one.
In May we Marlow Fluid Technology business had 27.4 million at 31st December 2016: a net were delighted to welcome Gestra to the another strong year, which saw organic debt to EBITDA ratio of 1.4 times.
Gestras market-leading automated sales up 10%.
The Spirax Sarco business The interim dividend for 2017, paid on 10th boiler controls and strong market position in also performed well with organic sales up November 2017, was raised by 13% to Germany increases the market share of our 5% and gains in all segments.
Gestra, which 25.5 pence per share 2016: 22.5 pence Steam Specialties division, improves access is reported within the Spirax Sarco Steam per share.
The Board is recommending to the German market and provides potential Specialties division, performed in line with an increase in the final dividend of 16% to to grow Gestras presence outside its core our expectations as did Chromalox, which 62.0 pence per share 2016: 53.5 pence.
Two months later, in July, is reported as a separate division within the Subject to approval of the final dividend by electrical process heating and temperature Spirax Sarco business.
shareholders at the AGM on 15th May 2018, management solutions provider, Chromalox, Group adjusted operating profit increased the total Ordinary dividend for the year is joined the Group.
Industrial electrical heating by 6% on an organic basis to a reported therefore 87.5 pence per share, an increase solutions are complementary to our steam 235.5 million.
Watson-Marlow delivered of 15% over the 76.0 pence per share for business and Chromaloxs direct sales organic profit growth of 6%, with the Steam the prior year.
business model, based around application Specialties division up 6% organically.
selling, diverse customer base and broad Favourable translation and transaction Corporate governance market diversity, make it an ideal fit.
currency movements increased adjusted As we announced on 14th February, I operating profit by 9% while acquisitions Three other important milestones have also have indicated my intention to retire from added 14%, resulting in adjusted operating been reached.
In 2017, Group sales reached the Board after this years Annual General profit being up 30%.
The adjusted operating 1 billion, the Groups underlying trading Meeting on 15th May 2018 AGM, having margin fell by 20 bps, to 23.6% as a result margin, excluding acquisitions, exceeded served as a Director for 16 years and as of the dilutionary effect of the two large 24% and the proposed dividend marks the Chairman for the past nine years.
acquisitions made in the year.
Excluding the 50th consecutive year of progress.
It is proposed that Jamie Pike, the current effects of acquisitions the underlying margin Senior Independent Director who joined the The events of 2017 demonstrate that we increased 90 bps to 24.7%.
Board in 2014, will take over as Chairman are not content to let external circumstances with effect from the close of the AGM.
As a dictate Group performance and outcomes, consequence of Jamies appointment, it but are actively engaged in engineering The events of 2017 demonstrate that we are not content to let external circumstances dictate Group performance and outcomes, but are actively engaged in engineering opportunities for sustainable growth.
Bill Whiteley Chairman 04 Spirax-Sarco Engineering plc Annual Report 2017 Strategic Report is also proposed that Clive Watson be Following two years of foreign exchange Steam Specialties division, excluding Gestra, appointed as the Senior Independent Director.
tailwinds, sterling has strengthened against we anticipate maintaining the same level of Clive will continue as Chairman of the Audit most of the currencies that we trade in and operating margins achieved in the full year Committee.
All appointments are subject to therefore we expect a currency headwind 2017.
However, due to the proportionally the re-election of Directors at the AGM.
If current exchange rates were to higher investments for growth in Watsonprevail for the remainder of the year, 2017s Marlow and Gestra, we anticipate a small Jamie Pike will, on appointment as revenues would have been 2% lower and margin decline for these businesses in 2018, Chairman, resign as a member of the trading profit would have been 4% lower.
similar to Watson-Marlows organic decline Audit Committee and the Remuneration Movements in exchange rates are often in 2017.
Committee in compliance with the volatile and unpredictable, therefore the Code.
He will Chair the Board and the Assuming no significant deterioration in actual impact could be significantly different.
trading conditions, the Board expects to For 2018, given the recent changes to the make further progress in 2018.
In anticipation of these changes we initiated composition of the Group and the volatility a search for an additional Independent Nonof the main currencies we trade in, we have Executive Director and on 6th March we We confirm that to the best chosen to provide additional information announced that Peter France will join the Board of our knowledge: in this outlook.
Considering the current with immediate effect.
Peter will be a member industrial production growth rates, we would of the Audit, Remuneration and Nomination The Financial Statements, prepared expect a similar organic growth performance Committees.
From 2008 to July 2017, Peter in accordance with the applicable set in the Spirax Sarco Steam Specialties was Chief Executive at Rotork plc.
of accounting standards, give a true division as seen in 2017.
As we continue and fair view of the assets, liabilities, Employees the integration of the Gestra and Chromalox financial position and profit or loss of On behalf of the Board, I would like to acquisitions, we expect these companies the Company and the undertakings welcome our new Gestra and Chromalox to grow at rates similar to global industrial included in the consolidation, taken as colleagues to the Group and to thank all our production growth, over their full year 2017 a whole.
employees throughout the world for their sales of 223 million.
Watson-Marlows The Annual Report for 2017, taken revenue growth was higher than expected in individual and collective contributions that as a whole, is fair, balanced and have enabled us to deliver another excellent 2017 as a number of larger orders booked in understandable, and provides set of results in 2017. late 2016 were shipped in 2017.
Therefore, the information necessary for we maintain our expectations of mid-to-high shareholders to assess the Groups Summary and outlook single-digit organic sales growth for the performance, business model Global industrial production growth rates, Watson-Marlow Fluid Technology business and strategy.
which are a good indicator of our market in 2018. conditions, strengthened throughout the year The Directors have a reasonable Excluding acquisitions, the 2017 trading resulting in growth of 3.4% in 2017 compared expectation that the Company will margin improved by 90 bps to 24.7%, with 0.9% in 2016 and 0.3% in 2015. be able to continue in operation and due to the effects of positive exchange meet its liabilities as they fall due Current indications for the industrial movements.
As anticipated, the underlying over the three-year period to 31st production growth rate in 2018 suggest margins remained constant as we reinvested December 2020.
For the full Viability that it will be at a similar level to that seen in operational gearing gains in the business.
We will remain focused on engineering Looking forward, we will continue investing The Annual Report contains the opportunities for self-generated growth, in the business for growth while also taking information required for compliance through the rigorous implementation of our actions to mitigate the adverse transactional strategy.
As we integrate and develop the with the Companies, Partnerships currency effects on margins that could occur recent acquisitions, we are also laying the and Groups and Non-Financial if current exchange rates prevail throughout Reporting Regulations 2016. foundations for their future organic growth.
Therefore, for Chromalox and the The Non-Financial Information Statement comprises information found on pages 12 to 15 business Basic earnings per share p KPI Dividend per share p model, pages 30 to 33 risks, and pages 52 to 61 environmental 2017 220.5 2017 87.5 matters, the Companys employees, 2016 171.5 2016 76.0 social matters, respect for human rights, and anti-corruption and anti- 2015 142.6 2015 69.0 bribery matters.
Signed by: Based on adjusted operating profit.
Special dividend Bill Whiteley Chairman on behalf of the Board of Directors 14th March 2018 Spirax-Sarco Engineering plc Annual Report 2017 05 Corporate Information Financial Statements Governance Report Strategic Report
